Cookie policy: This site uses cookies (small files stored on your computer) to simplify and improve your experience of this website. Cookies are small text files stored on the device you are using to access this website. For more information please take a look at our terms and conditions. Some parts of the site may not work properly if you choose not to accept cookies.

Join

Subscribe or Register

Existing user? Login

Medicines shortages

More than 60% of pharmacists spend at least an hour per day on medicines shortages

The Pharmacists’ Defence Association also found that 81% of pharmacists expect medicines shortages to get worse after a no-deal Brexit.

Some six in ten pharmacists (62%) have said they spend at least one hour every day dealing with issues relating to medicines shortages, according to results of a survey carried out by the Pharmacists’ Defence Association (PDA).

The ‘PDA Brexit medicines survey’, launched on 22 August 2019 and published on 27 September 2019, asked pharmacists about problems with medicines supply and the possible impact of Brexit.

The results show that 90% of the 1,071 pharmacists who responded thought that medicines shortages had increased over the past 12 months, with shortages said to have affected 21% of prescription drugs over the past three months.

Furthermore, 81% of respondents thought that medicine shortages would get worse after a no-deal Brexit, with 55% saying they thought the shortages would get “much worse”.

Commenting on the survey, a spokesperson from the PDA told The Pharmaceutical Journal that the results “present a stark picture of the huge stresses which drug shortages are causing for both pharmacists and patients”.

“Whilst these shortages cannot be ascribed to Brexit, they do show the need for concerted action to ensure that leaving the EU will not exacerbate an already unacceptable level of drug shortages,” they added.

Prior to the survey’s launch, a statement issued by the PDA on 7 August 2019 warned that it would “potentially be frontline pharmacists that face patients, and their carers and families, and have to spend the time explaining what alternative options exist in the event of a medicines shortage crisis” after Brexit.

Pharmacists and pharmacy bodies have already voiced their concerns to The Pharmaceutical Journal about the government’s claims that it is ready to leave the EU without a deal in place.

Citation: The Pharmaceutical Journal DOI: 10.1211/PJ.2019.20207128

Have your say

For commenting, please login or register as a user and agree to our Community Guidelines. You will be re-directed back to this page where you will have the ability to comment.

Recommended from Pharmaceutical Press

Search an extensive range of the world’s most trusted resources

Powered by MedicinesComplete
  • Print
  • Share
  • Comment
  • Save
  • Print Friendly Version of this pagePrint Get a PDF version of this webpagePDF

Jobs you might like

Newsletter Sign-up

Want to keep up with the latest news, comment and CPD articles in pharmacy and science? Subscribe to our free alerts.